SCHEMBL8999545

SCHEMBL8999545

CC(=O)N(C(C)=O)C1c2ccccc2-c2ccccc21

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR3 P46089 1/20 0.54
POLB P06746 2/20 0.50
KMT2A Q03164 2/20 0.46
SLC22A2 O15244 1/20 0.43
SLC22A3 O75751 1/20 0.43
HDAC3 O15379 1/20 0.42
HDAC4 P56524 1/20 0.42
HDAC7 Q8WUI4 1/20 0.42
HDAC8 Q9BY41 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
HDAC9 Q9UKV0 1/20 0.42
HDAC5 Q9UQL6 1/20 0.42
NCOR2 Q9Y618 1/20 0.42
MAPT P10636 4/20 0.40
MEN1 O00255 1/20 0.39
LMNA P02545 1/20 0.39
CYP1A2 P05177 2/20 0.38
TSHR P16473 2/20 0.38
CYP2C19 P33261 1/20 0.38
ALDH1A1 P00352 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27403304 0.83 GPR3 (0.54) GPR3POLBKMT2ASLC22A2SLC22A3
SCHEMBL29202280 0.80 GPR3 (0.50) GPR3POLBKMT2ASLC22A2SLC22A3
SCHEMBL6038134 0.76 POLB (0.51) GPR3POLBKMT2ASLC22A2SLC22A3
SCHEMBL17456836 0.74 GPR3 (0.44) GPR3POLBKMT2ASLC22A2SLC22A3
SCHEMBL88303 0.73 GPR3 (0.57) GPR3POLBKMT2ASLC22A2SLC22A3
SCHEMBL9398144 0.72 KMT2A (0.42) GPR3POLBKMT2ASLC22A2SLC22A3
SCHEMBL27838676 0.72 GPR3 (0.42) GPR3POLBKMT2ASLC22A2SLC22A3
SCHEMBL7043488 0.71 HDAC3 (0.57) GPR3POLBKMT2AHDAC3HDAC4
Acetone SCHEMBL8469766 0.71 POLB (0.55) GPR3POLBKMT2AHDAC3HDAC4
Carbamic Acid SCHEMBL27661544 0.71 GPR3 (0.53) GPR3POLBKMT2ASLC22A2SLC22A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0097664-B1 PROCESS INVOLVING A PROBE CONTAINING A MODIFIED NUCLEIC ACID RECOGNIZABLE BY SPECIFIC ANTIBODIES AND ALLOWING TO TEST FOR AND CHARACTERIZE AN HOMOLOGOUS DNA SEQUENCE INSTITUT PASTEUR (FR) 1986-03-12 EP claimed
EP-0097664-A1 PROCESS INVOLVING A PROBE CONTAINING A MODIFIED NUCLEIC ACID RECOGNIZABLE BY SPECIFIC ANTIBODIES AND ALLOWING TO TEST FOR AND CHARACTERIZE AN HOMOLOGOUS DNA SEQUENCE. PASTEUR INSTITUT (FR) 1984-01-11 EP claimed
WO-1983002286-A1 PROBE CONTAINING A MODIFIED NUCLEIC ACID RECOGNIZABLE BY SPECIFIC ANTIBODIES AND UTILIZATION OF SAID PROBE TO TEST FOR AND CHARACTERIZE AN HOMOLOGOUS DNA SEQUENCE TCHEN, PAUL 1983-07-07 WO claimed
EP-0381823-B1 Cytotropic heterogenous molecular lipids (CHML) and process for preparing the same XU ZHENG (CN) 1996-09-11 EP disclosed
US-5260067-A Squaleme, fatty acid, vitamins E, D and A, to target cancer cells for anticancer drug ZHENG XU (US) 1993-11-09 US disclosed
EP-0381823-A2 Cytotropic heterogenous molecular lipids (CHML) and process for preparing the same Xu, Zheng (CN) 1990-08-16 EP disclosed
EP-0158758-B1 PROBE CONTAINING A MODIFIED NUCLEIC ACID RECOGNIZABLE BY SPECIFIC ANTIBODIES AND THE USE TO DETECT AND CHARACTERIZE A HOMOLOGOUS DNA SEQUENCE INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) 1988-09-28 EP disclosed
EP-0097664-B1 PROCESS INVOLVING A PROBE CONTAINING A MODIFIED NUCLEIC ACID RECOGNIZABLE BY SPECIFIC ANTIBODIES AND ALLOWING TO TEST FOR AND CHARACTERIZE AN HOMOLOGOUS DNA SEQUENCE INSTITUT PASTEUR (FR) 1986-03-12 EP disclosed
EP-0158758-A1 Probe containing a modified nucleic acid recognizable by specific antibodies and the use to detect and characterize a homologous DNA sequence INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) 1985-10-23 EP disclosed